Kanzhun Authorizes New $1.2B Share Buyback Mandate and Reports $79.6M in Recent Repurchases
BZ is trading near its 52-week low of $12.57 (5.4% above the low).
Summary
Kanzhun Ltd. has authorized a new share repurchase mandate for up to 93.3 million shares, valued at approximately $1.23 billion at current prices, and reported the execution of $79.6 million in repurchases from May 27 to June 26.
Key Events · Financing and Capital Events · BZ
-
New Share Repurchase Mandate Authorized
On June 25, 2026, Kanzhun authorized a new mandate to repurchase up to 93,335,937 shares. At the current stock price of $13.25, this authorization is valued at approximately $1.23 billion, significantly expanding the company's capacity for future buybacks.
-
Significant Share Repurchases Executed
The company reported repurchasing 11,932,186 shares totaling approximately $79.6 million between May 27 and June 26, 2026, at an average price of $6.67 per share. These repurchases were made at a substantial discount to the current market price of $13.25.
-
Minor Share Issuances
A total of 9,070 shares were issued on June 26, 2026, due to the exercise of share options and vesting of restricted share units, which is a routine event related to employee incentive plans.
Analysis · BZ · Technology
This filing highlights Kanzhun's aggressive capital return strategy. The authorization of a new share repurchase mandate for up to 93.3 million shares, representing over 20% of the company's market capitalization, signals a significant commitment to enhancing shareholder value. This new mandate substantially increases the company's capacity for future buybacks beyond its existing $400 million program. The reported $79.6 million in executed repurchases, made at an average price significantly below the current market price, further demonstrates management's confidence and proactive approach to capital management.
At the time of this filing, BZ was trading at $13.25 on NASDAQ in the Technology sector, with a market capitalization of approximately $5.9B. The 52-week trading range was $12.57 to $25.26. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.